Drugs / BG-C9074
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06233942 | Apr 2024 → Sep 2027 expected | neoplasm | BeOne Medicines | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG-C9074 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06233942 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT06233942 ↗ |